Global Vaccines & Vaccination Market

Vaccines & Vaccination Comprehensive Study by Type (Monovalent Vaccines, Multivalent Vaccines), Application (Pediatrics disease, Adults disease), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, Other Routes of Administration), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), Disease (Pneumococcal Disease, Influenza, DTP, Hepatitis, Human Papilloma Virus (HPV), Rotavirus, Meningococcal Disease, MMR (measles, mumps, and rubella), Varicella, Polio, Herpes Zoster, Dengue, Other Disease Indications) Players and Region - Global Market Outlook to 2026

Vaccines & Vaccination Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 5.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Vaccines & Vaccination Market Scope
Vaccine is an antigenic substance prepared to kill microorganisms, living attenuated organisms, or living fully virulent organisms that is administered to produce or artificially increase immunity to a particular disease. The rising prevalence of several infectious diseases is rising demand for vaccine market. The healthcare infrastructure and high awareness levels of the benefits of immunization are the major factors boosting the market growth.

According to AMA, the Global Vaccines & Vaccination market is expected to see growth rate of 5.8% and may see market size of USD51.45 Million by 2026.

There are relatively very few vaccine manufacturers that meet the international standard, due to which the individual vaccine manufacturer, the market become monopolies or oligopoly either by product or presentation. Very, few suppliers and production capacities lead to a tenuous balance between demand and supply in many individual vaccine markets. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Vaccines & Vaccination market throughout the predicted period.

Pfizer, Inc. (United States), Merck & Co., Inc. (United States), Emergent BioSolutions, Inc. (United States), Johnson & Johnson (United States), MedImmune, LLC (United States), GlaxoSmithKline plc (UK), Sanofi Pasteur (France), Astellas Pharma Inc. (Japan), CSL Limited (Australia) and Serum Institute of India Pvt. Ltd. (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan), Biological E (India) and Panacea Biotec (India).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Vaccines & Vaccination market by Type (Monovalent Vaccines and Multivalent Vaccines), by Application (Pediatrics disease and Adults disease) and Region with country level break-up.

On the basis of geography, the market of Vaccines & Vaccination has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

According to WHO, about 80% of global vaccine sales from five large multinational corporations that were the product of various mergers and acquisitions of pharmaceutical companies over the past decades.
WHO ensures the safety and quality of vaccine and works closely on global standards which are developed and made readily available. WHO provides norms and standard and give advice to procurement agencies and countries on the acceptability, in principle of vaccines. It has also established the Global Advisory committee on vaccine safety which includes national experts and authority to support vaccine safety.

Market Trend
  • Development of vaccines administered orally is preferable
  • Technology advancement in molecular genetics domain

Market Drivers
  • Rise in infectious diseases
  • Increasing government initiative’s and support for the vaccine in various region
  • High focus on immunization program around the globe
  • Rise in awareness about Vaccination in emerging countries

Opportunities
  • High growth prospectus in various regions due to increasing infection
  • Focus on therapeutic vaccines
  • Increasing use of adjuvants in vaccine

Restraints
  • High cost involved in vaccine development

Challenges
  • Time consuming process for producing vaccines


Key Target Audience
Manufacturers and suppliers of vaccines, Research and development companies, Medical research laboratories, Academic medical centers and universities, Research and consulting firms and Venture capital firms

Report Objectives / Segmentation Covered

By Type
  • Monovalent Vaccines
  • Multivalent Vaccines
By Application
  • Pediatrics disease
  • Adults disease
By Route of Administration
  • Intramuscular and Subcutaneous Administration
  • Oral Administration
  • Other Routes of Administration

By Technology
  • Conjugate Vaccines
  • Inactivated and Subunit Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines

By Disease
  • Pneumococcal Disease
  • Influenza
  • DTP
  • Hepatitis
  • Human Papilloma Virus (HPV)
  • Rotavirus
  • Meningococcal Disease
  • MMR (measles, mumps, and rubella)
  • Varicella
  • Polio
  • Herpes Zoster
  • Dengue
  • Other Disease Indications

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in infectious diseases
      • 3.2.2. Increasing government initiative’s and support for the vaccine in various region
      • 3.2.3. High focus on immunization program around the globe
      • 3.2.4. Rise in awareness about Vaccination in emerging countries
    • 3.3. Market Challenges
      • 3.3.1. Time consuming process for producing vaccines
    • 3.4. Market Trends
      • 3.4.1. Development of vaccines administered orally is preferable
      • 3.4.2. Technology advancement in molecular genetics domain
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Vaccines & Vaccination, by Type, Application, Route of Administration, Technology , Disease and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Vaccines & Vaccination (Value)
      • 5.2.1. Global Vaccines & Vaccination by: Type (Value)
        • 5.2.1.1. Monovalent Vaccines
        • 5.2.1.2. Multivalent Vaccines
      • 5.2.2. Global Vaccines & Vaccination by: Application (Value)
        • 5.2.2.1. Pediatrics disease
        • 5.2.2.2. Adults disease
      • 5.2.3. Global Vaccines & Vaccination by: Route of Administration (Value)
        • 5.2.3.1. Intramuscular and Subcutaneous Administration
        • 5.2.3.2. Oral Administration
        • 5.2.3.3. Other Routes of Administration
      • 5.2.4. Global Vaccines & Vaccination Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Vaccines & Vaccination (Volume)
      • 5.3.1. Global Vaccines & Vaccination by: Type (Volume)
        • 5.3.1.1. Monovalent Vaccines
        • 5.3.1.2. Multivalent Vaccines
      • 5.3.2. Global Vaccines & Vaccination by: Application (Volume)
        • 5.3.2.1. Pediatrics disease
        • 5.3.2.2. Adults disease
      • 5.3.3. Global Vaccines & Vaccination by: Route of Administration (Volume)
        • 5.3.3.1. Intramuscular and Subcutaneous Administration
        • 5.3.3.2. Oral Administration
        • 5.3.3.3. Other Routes of Administration
      • 5.3.4. Global Vaccines & Vaccination Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Vaccines & Vaccination (Price)
      • 5.4.1. Global Vaccines & Vaccination by: Type (Price)
  • 6. Vaccines & Vaccination: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co., Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Emergent BioSolutions, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Johnson & Johnson (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. MedImmune, LLC (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GlaxoSmithKline plc (UK)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi Pasteur (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Astellas Pharma Inc. (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CSL Limited (Australia)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Serum Institute of India Pvt. Ltd. (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Vaccines & Vaccination Sale, by Type, Application, Route of Administration, Technology , Disease and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Vaccines & Vaccination (Value)
      • 7.2.1. Global Vaccines & Vaccination by: Type (Value)
        • 7.2.1.1. Monovalent Vaccines
        • 7.2.1.2. Multivalent Vaccines
      • 7.2.2. Global Vaccines & Vaccination by: Application (Value)
        • 7.2.2.1. Pediatrics disease
        • 7.2.2.2. Adults disease
      • 7.2.3. Global Vaccines & Vaccination by: Route of Administration (Value)
        • 7.2.3.1. Intramuscular and Subcutaneous Administration
        • 7.2.3.2. Oral Administration
        • 7.2.3.3. Other Routes of Administration
      • 7.2.4. Global Vaccines & Vaccination Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Vaccines & Vaccination (Volume)
      • 7.3.1. Global Vaccines & Vaccination by: Type (Volume)
        • 7.3.1.1. Monovalent Vaccines
        • 7.3.1.2. Multivalent Vaccines
      • 7.3.2. Global Vaccines & Vaccination by: Application (Volume)
        • 7.3.2.1. Pediatrics disease
        • 7.3.2.2. Adults disease
      • 7.3.3. Global Vaccines & Vaccination by: Route of Administration (Volume)
        • 7.3.3.1. Intramuscular and Subcutaneous Administration
        • 7.3.3.2. Oral Administration
        • 7.3.3.3. Other Routes of Administration
      • 7.3.4. Global Vaccines & Vaccination Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Vaccines & Vaccination (Price)
      • 7.4.1. Global Vaccines & Vaccination by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Vaccines & Vaccination: by Type(USD Million)
  • Table 2. Vaccines & Vaccination Monovalent Vaccines , by Region USD Million (2015-2020)
  • Table 3. Vaccines & Vaccination Multivalent Vaccines , by Region USD Million (2015-2020)
  • Table 4. Vaccines & Vaccination: by Application(USD Million)
  • Table 5. Vaccines & Vaccination Pediatrics disease , by Region USD Million (2015-2020)
  • Table 6. Vaccines & Vaccination Adults disease , by Region USD Million (2015-2020)
  • Table 7. Vaccines & Vaccination: by Route of Administration(USD Million)
  • Table 8. Vaccines & Vaccination Intramuscular and Subcutaneous Administration , by Region USD Million (2015-2020)
  • Table 9. Vaccines & Vaccination Oral Administration , by Region USD Million (2015-2020)
  • Table 10. Vaccines & Vaccination Other Routes of Administration , by Region USD Million (2015-2020)
  • Table 11. South America Vaccines & Vaccination, by Country USD Million (2015-2020)
  • Table 12. South America Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 13. South America Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 14. South America Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 15. South America Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 16. South America Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 17. Brazil Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 18. Brazil Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 19. Brazil Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 20. Brazil Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 21. Brazil Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 22. Argentina Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 23. Argentina Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 24. Argentina Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 25. Argentina Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 26. Argentina Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 27. Rest of South America Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 28. Rest of South America Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 29. Rest of South America Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 30. Rest of South America Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 31. Rest of South America Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 32. Asia Pacific Vaccines & Vaccination, by Country USD Million (2015-2020)
  • Table 33. Asia Pacific Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 34. Asia Pacific Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 35. Asia Pacific Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 36. Asia Pacific Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 37. Asia Pacific Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 38. China Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 39. China Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 40. China Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 41. China Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 42. China Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 43. Japan Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 44. Japan Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 45. Japan Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 46. Japan Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 47. Japan Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 48. India Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 49. India Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 50. India Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 51. India Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 52. India Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 53. South Korea Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 54. South Korea Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 55. South Korea Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 56. South Korea Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 57. South Korea Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 58. Taiwan Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 59. Taiwan Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 60. Taiwan Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 61. Taiwan Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 62. Taiwan Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 63. Australia Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 64. Australia Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 65. Australia Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 66. Australia Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 67. Australia Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 73. Europe Vaccines & Vaccination, by Country USD Million (2015-2020)
  • Table 74. Europe Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 75. Europe Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 76. Europe Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 77. Europe Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 78. Europe Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 79. Germany Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 80. Germany Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 81. Germany Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 82. Germany Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 83. Germany Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 84. France Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 85. France Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 86. France Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 87. France Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 88. France Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 89. Italy Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 90. Italy Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 91. Italy Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 92. Italy Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 93. Italy Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 94. United Kingdom Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 95. United Kingdom Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 96. United Kingdom Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 97. United Kingdom Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 98. United Kingdom Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 99. Netherlands Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 100. Netherlands Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 101. Netherlands Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 102. Netherlands Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 103. Netherlands Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 104. Rest of Europe Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 105. Rest of Europe Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 106. Rest of Europe Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 107. Rest of Europe Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 108. Rest of Europe Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 109. MEA Vaccines & Vaccination, by Country USD Million (2015-2020)
  • Table 110. MEA Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 111. MEA Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 112. MEA Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 113. MEA Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 114. MEA Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 115. Middle East Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 116. Middle East Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 117. Middle East Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 118. Middle East Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 119. Middle East Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 120. Africa Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 121. Africa Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 122. Africa Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 123. Africa Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 124. Africa Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 125. North America Vaccines & Vaccination, by Country USD Million (2015-2020)
  • Table 126. North America Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 127. North America Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 128. North America Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 129. North America Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 130. North America Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 131. United States Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 132. United States Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 133. United States Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 134. United States Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 135. United States Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 136. Canada Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 137. Canada Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 138. Canada Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 139. Canada Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 140. Canada Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 141. Mexico Vaccines & Vaccination, by Type USD Million (2015-2020)
  • Table 142. Mexico Vaccines & Vaccination, by Application USD Million (2015-2020)
  • Table 143. Mexico Vaccines & Vaccination, by Route of Administration USD Million (2015-2020)
  • Table 144. Mexico Vaccines & Vaccination, by Technology USD Million (2015-2020)
  • Table 145. Mexico Vaccines & Vaccination, by Disease USD Million (2015-2020)
  • Table 146. Vaccines & Vaccination Sales: by Type(Doses)
  • Table 147. Vaccines & Vaccination Sales Monovalent Vaccines , by Region Doses (2015-2020)
  • Table 148. Vaccines & Vaccination Sales Multivalent Vaccines , by Region Doses (2015-2020)
  • Table 149. Vaccines & Vaccination Sales: by Application(Doses)
  • Table 150. Vaccines & Vaccination Sales Pediatrics disease , by Region Doses (2015-2020)
  • Table 151. Vaccines & Vaccination Sales Adults disease , by Region Doses (2015-2020)
  • Table 152. Vaccines & Vaccination Sales: by Route of Administration(Doses)
  • Table 153. Vaccines & Vaccination Sales Intramuscular and Subcutaneous Administration , by Region Doses (2015-2020)
  • Table 154. Vaccines & Vaccination Sales Oral Administration , by Region Doses (2015-2020)
  • Table 155. Vaccines & Vaccination Sales Other Routes of Administration , by Region Doses (2015-2020)
  • Table 156. South America Vaccines & Vaccination Sales, by Country Doses (2015-2020)
  • Table 157. South America Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 158. South America Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 159. South America Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 160. South America Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 161. South America Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 162. Brazil Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 163. Brazil Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 164. Brazil Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 165. Brazil Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 166. Brazil Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 167. Argentina Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 168. Argentina Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 169. Argentina Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 170. Argentina Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 171. Argentina Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 172. Rest of South America Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 173. Rest of South America Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 174. Rest of South America Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 175. Rest of South America Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 176. Rest of South America Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 177. Asia Pacific Vaccines & Vaccination Sales, by Country Doses (2015-2020)
  • Table 178. Asia Pacific Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 179. Asia Pacific Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 180. Asia Pacific Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 181. Asia Pacific Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 182. Asia Pacific Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 183. China Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 184. China Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 185. China Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 186. China Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 187. China Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 188. Japan Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 189. Japan Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 190. Japan Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 191. Japan Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 192. Japan Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 193. India Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 194. India Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 195. India Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 196. India Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 197. India Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 198. South Korea Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 199. South Korea Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 200. South Korea Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 201. South Korea Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 202. South Korea Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 203. Taiwan Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 204. Taiwan Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 205. Taiwan Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 206. Taiwan Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 207. Taiwan Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 208. Australia Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 209. Australia Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 210. Australia Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 211. Australia Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 212. Australia Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 213. Rest of Asia-Pacific Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 214. Rest of Asia-Pacific Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 215. Rest of Asia-Pacific Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 216. Rest of Asia-Pacific Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 217. Rest of Asia-Pacific Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 218. Europe Vaccines & Vaccination Sales, by Country Doses (2015-2020)
  • Table 219. Europe Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 220. Europe Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 221. Europe Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 222. Europe Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 223. Europe Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 224. Germany Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 225. Germany Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 226. Germany Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 227. Germany Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 228. Germany Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 229. France Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 230. France Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 231. France Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 232. France Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 233. France Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 234. Italy Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 235. Italy Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 236. Italy Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 237. Italy Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 238. Italy Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 239. United Kingdom Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 240. United Kingdom Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 241. United Kingdom Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 242. United Kingdom Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 243. United Kingdom Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 244. Netherlands Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 245. Netherlands Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 246. Netherlands Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 247. Netherlands Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 248. Netherlands Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 249. Rest of Europe Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 250. Rest of Europe Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 251. Rest of Europe Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 252. Rest of Europe Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 253. Rest of Europe Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 254. MEA Vaccines & Vaccination Sales, by Country Doses (2015-2020)
  • Table 255. MEA Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 256. MEA Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 257. MEA Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 258. MEA Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 259. MEA Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 260. Middle East Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 261. Middle East Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 262. Middle East Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 263. Middle East Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 264. Middle East Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 265. Africa Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 266. Africa Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 267. Africa Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 268. Africa Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 269. Africa Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 270. North America Vaccines & Vaccination Sales, by Country Doses (2015-2020)
  • Table 271. North America Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 272. North America Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 273. North America Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 274. North America Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 275. North America Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 276. United States Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 277. United States Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 278. United States Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 279. United States Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 280. United States Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 281. Canada Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 282. Canada Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 283. Canada Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 284. Canada Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 285. Canada Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 286. Mexico Vaccines & Vaccination Sales, by Type Doses (2015-2020)
  • Table 287. Mexico Vaccines & Vaccination Sales, by Application Doses (2015-2020)
  • Table 288. Mexico Vaccines & Vaccination Sales, by Route of Administration Doses (2015-2020)
  • Table 289. Mexico Vaccines & Vaccination Sales, by Technology Doses (2015-2020)
  • Table 290. Mexico Vaccines & Vaccination Sales, by Disease Doses (2015-2020)
  • Table 291. Vaccines & Vaccination: by Type(USD/Units)
  • Table 292. Company Basic Information, Sales Area and Its Competitors
  • Table 293. Company Basic Information, Sales Area and Its Competitors
  • Table 294. Company Basic Information, Sales Area and Its Competitors
  • Table 295. Company Basic Information, Sales Area and Its Competitors
  • Table 296. Company Basic Information, Sales Area and Its Competitors
  • Table 297. Company Basic Information, Sales Area and Its Competitors
  • Table 298. Company Basic Information, Sales Area and Its Competitors
  • Table 299. Company Basic Information, Sales Area and Its Competitors
  • Table 300. Company Basic Information, Sales Area and Its Competitors
  • Table 301. Company Basic Information, Sales Area and Its Competitors
  • Table 302. Vaccines & Vaccination: by Type(USD Million)
  • Table 303. Vaccines & Vaccination Monovalent Vaccines , by Region USD Million (2021-2026)
  • Table 304. Vaccines & Vaccination Multivalent Vaccines , by Region USD Million (2021-2026)
  • Table 305. Vaccines & Vaccination: by Application(USD Million)
  • Table 306. Vaccines & Vaccination Pediatrics disease , by Region USD Million (2021-2026)
  • Table 307. Vaccines & Vaccination Adults disease , by Region USD Million (2021-2026)
  • Table 308. Vaccines & Vaccination: by Route of Administration(USD Million)
  • Table 309. Vaccines & Vaccination Intramuscular and Subcutaneous Administration , by Region USD Million (2021-2026)
  • Table 310. Vaccines & Vaccination Oral Administration , by Region USD Million (2021-2026)
  • Table 311. Vaccines & Vaccination Other Routes of Administration , by Region USD Million (2021-2026)
  • Table 312. South America Vaccines & Vaccination, by Country USD Million (2021-2026)
  • Table 313. South America Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 314. South America Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 315. South America Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 316. South America Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 317. South America Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 318. Brazil Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 319. Brazil Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 320. Brazil Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 321. Brazil Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 322. Brazil Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 323. Argentina Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 324. Argentina Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 325. Argentina Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 326. Argentina Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 327. Argentina Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 328. Rest of South America Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 329. Rest of South America Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 330. Rest of South America Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 331. Rest of South America Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 332. Rest of South America Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 333. Asia Pacific Vaccines & Vaccination, by Country USD Million (2021-2026)
  • Table 334. Asia Pacific Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 335. Asia Pacific Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 336. Asia Pacific Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 337. Asia Pacific Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 338. Asia Pacific Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 339. China Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 340. China Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 341. China Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 342. China Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 343. China Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 344. Japan Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 345. Japan Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 346. Japan Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 347. Japan Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 348. Japan Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 349. India Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 350. India Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 351. India Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 352. India Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 353. India Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 354. South Korea Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 355. South Korea Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 356. South Korea Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 357. South Korea Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 358. South Korea Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 359. Taiwan Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 360. Taiwan Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 361. Taiwan Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 362. Taiwan Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 363. Taiwan Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 364. Australia Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 365. Australia Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 366. Australia Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 367. Australia Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 368. Australia Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 369. Rest of Asia-Pacific Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 370. Rest of Asia-Pacific Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 371. Rest of Asia-Pacific Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 372. Rest of Asia-Pacific Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 373. Rest of Asia-Pacific Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 374. Europe Vaccines & Vaccination, by Country USD Million (2021-2026)
  • Table 375. Europe Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 376. Europe Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 377. Europe Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 378. Europe Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 379. Europe Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 380. Germany Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 381. Germany Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 382. Germany Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 383. Germany Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 384. Germany Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 385. France Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 386. France Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 387. France Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 388. France Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 389. France Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 390. Italy Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 391. Italy Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 392. Italy Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 393. Italy Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 394. Italy Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 395. United Kingdom Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 396. United Kingdom Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 397. United Kingdom Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 398. United Kingdom Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 399. United Kingdom Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 400. Netherlands Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 401. Netherlands Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 402. Netherlands Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 403. Netherlands Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 404. Netherlands Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 405. Rest of Europe Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 406. Rest of Europe Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 407. Rest of Europe Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 408. Rest of Europe Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 409. Rest of Europe Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 410. MEA Vaccines & Vaccination, by Country USD Million (2021-2026)
  • Table 411. MEA Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 412. MEA Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 413. MEA Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 414. MEA Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 415. MEA Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 416. Middle East Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 417. Middle East Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 418. Middle East Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 419. Middle East Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 420. Middle East Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 421. Africa Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 422. Africa Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 423. Africa Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 424. Africa Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 425. Africa Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 426. North America Vaccines & Vaccination, by Country USD Million (2021-2026)
  • Table 427. North America Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 428. North America Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 429. North America Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 430. North America Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 431. North America Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 432. United States Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 433. United States Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 434. United States Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 435. United States Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 436. United States Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 437. Canada Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 438. Canada Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 439. Canada Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 440. Canada Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 441. Canada Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 442. Mexico Vaccines & Vaccination, by Type USD Million (2021-2026)
  • Table 443. Mexico Vaccines & Vaccination, by Application USD Million (2021-2026)
  • Table 444. Mexico Vaccines & Vaccination, by Route of Administration USD Million (2021-2026)
  • Table 445. Mexico Vaccines & Vaccination, by Technology USD Million (2021-2026)
  • Table 446. Mexico Vaccines & Vaccination, by Disease USD Million (2021-2026)
  • Table 447. Vaccines & Vaccination Sales: by Type(Doses)
  • Table 448. Vaccines & Vaccination Sales Monovalent Vaccines , by Region Doses (2021-2026)
  • Table 449. Vaccines & Vaccination Sales Multivalent Vaccines , by Region Doses (2021-2026)
  • Table 450. Vaccines & Vaccination Sales: by Application(Doses)
  • Table 451. Vaccines & Vaccination Sales Pediatrics disease , by Region Doses (2021-2026)
  • Table 452. Vaccines & Vaccination Sales Adults disease , by Region Doses (2021-2026)
  • Table 453. Vaccines & Vaccination Sales: by Route of Administration(Doses)
  • Table 454. Vaccines & Vaccination Sales Intramuscular and Subcutaneous Administration , by Region Doses (2021-2026)
  • Table 455. Vaccines & Vaccination Sales Oral Administration , by Region Doses (2021-2026)
  • Table 456. Vaccines & Vaccination Sales Other Routes of Administration , by Region Doses (2021-2026)
  • Table 457. South America Vaccines & Vaccination Sales, by Country Doses (2021-2026)
  • Table 458. South America Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 459. South America Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 460. South America Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 461. South America Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 462. South America Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 463. Brazil Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 464. Brazil Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 465. Brazil Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 466. Brazil Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 467. Brazil Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 468. Argentina Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 469. Argentina Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 470. Argentina Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 471. Argentina Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 472. Argentina Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 473. Rest of South America Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 474. Rest of South America Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 475. Rest of South America Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 476. Rest of South America Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 477. Rest of South America Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 478. Asia Pacific Vaccines & Vaccination Sales, by Country Doses (2021-2026)
  • Table 479. Asia Pacific Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 480. Asia Pacific Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 481. Asia Pacific Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 482. Asia Pacific Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 483. Asia Pacific Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 484. China Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 485. China Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 486. China Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 487. China Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 488. China Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 489. Japan Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 490. Japan Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 491. Japan Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 492. Japan Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 493. Japan Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 494. India Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 495. India Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 496. India Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 497. India Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 498. India Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 499. South Korea Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 500. South Korea Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 501. South Korea Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 502. South Korea Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 503. South Korea Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 504. Taiwan Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 505. Taiwan Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 506. Taiwan Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 507. Taiwan Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 508. Taiwan Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 509. Australia Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 510. Australia Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 511. Australia Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 512. Australia Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 513. Australia Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 514. Rest of Asia-Pacific Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 515. Rest of Asia-Pacific Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 516. Rest of Asia-Pacific Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 517. Rest of Asia-Pacific Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 518. Rest of Asia-Pacific Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 519. Europe Vaccines & Vaccination Sales, by Country Doses (2021-2026)
  • Table 520. Europe Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 521. Europe Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 522. Europe Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 523. Europe Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 524. Europe Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 525. Germany Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 526. Germany Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 527. Germany Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 528. Germany Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 529. Germany Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 530. France Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 531. France Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 532. France Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 533. France Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 534. France Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 535. Italy Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 536. Italy Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 537. Italy Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 538. Italy Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 539. Italy Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 540. United Kingdom Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 541. United Kingdom Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 542. United Kingdom Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 543. United Kingdom Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 544. United Kingdom Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 545. Netherlands Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 546. Netherlands Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 547. Netherlands Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 548. Netherlands Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 549. Netherlands Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 550. Rest of Europe Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 551. Rest of Europe Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 552. Rest of Europe Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 553. Rest of Europe Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 554. Rest of Europe Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 555. MEA Vaccines & Vaccination Sales, by Country Doses (2021-2026)
  • Table 556. MEA Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 557. MEA Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 558. MEA Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 559. MEA Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 560. MEA Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 561. Middle East Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 562. Middle East Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 563. Middle East Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 564. Middle East Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 565. Middle East Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 566. Africa Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 567. Africa Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 568. Africa Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 569. Africa Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 570. Africa Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 571. North America Vaccines & Vaccination Sales, by Country Doses (2021-2026)
  • Table 572. North America Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 573. North America Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 574. North America Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 575. North America Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 576. North America Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 577. United States Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 578. United States Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 579. United States Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 580. United States Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 581. United States Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 582. Canada Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 583. Canada Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 584. Canada Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 585. Canada Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 586. Canada Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 587. Mexico Vaccines & Vaccination Sales, by Type Doses (2021-2026)
  • Table 588. Mexico Vaccines & Vaccination Sales, by Application Doses (2021-2026)
  • Table 589. Mexico Vaccines & Vaccination Sales, by Route of Administration Doses (2021-2026)
  • Table 590. Mexico Vaccines & Vaccination Sales, by Technology Doses (2021-2026)
  • Table 591. Mexico Vaccines & Vaccination Sales, by Disease Doses (2021-2026)
  • Table 592. Vaccines & Vaccination: by Type(USD/Units)
  • Table 593. Research Programs/Design for This Report
  • Table 594. Key Data Information from Secondary Sources
  • Table 595. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vaccines & Vaccination: by Type USD Million (2015-2020)
  • Figure 5. Global Vaccines & Vaccination: by Application USD Million (2015-2020)
  • Figure 6. Global Vaccines & Vaccination: by Route of Administration USD Million (2015-2020)
  • Figure 7. South America Vaccines & Vaccination Share (%), by Country
  • Figure 8. Asia Pacific Vaccines & Vaccination Share (%), by Country
  • Figure 9. Europe Vaccines & Vaccination Share (%), by Country
  • Figure 10. MEA Vaccines & Vaccination Share (%), by Country
  • Figure 11. North America Vaccines & Vaccination Share (%), by Country
  • Figure 12. Global Vaccines & Vaccination: by Type Doses (2015-2020)
  • Figure 13. Global Vaccines & Vaccination: by Application Doses (2015-2020)
  • Figure 14. Global Vaccines & Vaccination: by Route of Administration Doses (2015-2020)
  • Figure 15. South America Vaccines & Vaccination Share (%), by Country
  • Figure 16. Asia Pacific Vaccines & Vaccination Share (%), by Country
  • Figure 17. Europe Vaccines & Vaccination Share (%), by Country
  • Figure 18. MEA Vaccines & Vaccination Share (%), by Country
  • Figure 19. North America Vaccines & Vaccination Share (%), by Country
  • Figure 20. Global Vaccines & Vaccination: by Type USD/Units (2015-2020)
  • Figure 21. Global Vaccines & Vaccination share by Players 2020 (%)
  • Figure 22. Global Vaccines & Vaccination share by Players (Top 3) 2020(%)
  • Figure 23. Global Vaccines & Vaccination share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Merck & Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Emergent BioSolutions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Emergent BioSolutions, Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 32. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 33. MedImmune, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 34. MedImmune, LLC (United States) Revenue: by Geography 2020
  • Figure 35. GlaxoSmithKline plc (UK) Revenue, Net Income and Gross profit
  • Figure 36. GlaxoSmithKline plc (UK) Revenue: by Geography 2020
  • Figure 37. Sanofi Pasteur (France) Revenue, Net Income and Gross profit
  • Figure 38. Sanofi Pasteur (France) Revenue: by Geography 2020
  • Figure 39. Astellas Pharma Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 40. Astellas Pharma Inc. (Japan) Revenue: by Geography 2020
  • Figure 41. CSL Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 42. CSL Limited (Australia) Revenue: by Geography 2020
  • Figure 43. Serum Institute of India Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 44. Serum Institute of India Pvt. Ltd. (India) Revenue: by Geography 2020
  • Figure 45. Global Vaccines & Vaccination: by Type USD Million (2021-2026)
  • Figure 46. Global Vaccines & Vaccination: by Application USD Million (2021-2026)
  • Figure 47. Global Vaccines & Vaccination: by Route of Administration USD Million (2021-2026)
  • Figure 48. South America Vaccines & Vaccination Share (%), by Country
  • Figure 49. Asia Pacific Vaccines & Vaccination Share (%), by Country
  • Figure 50. Europe Vaccines & Vaccination Share (%), by Country
  • Figure 51. MEA Vaccines & Vaccination Share (%), by Country
  • Figure 52. North America Vaccines & Vaccination Share (%), by Country
  • Figure 53. Global Vaccines & Vaccination: by Type Doses (2021-2026)
  • Figure 54. Global Vaccines & Vaccination: by Application Doses (2021-2026)
  • Figure 55. Global Vaccines & Vaccination: by Route of Administration Doses (2021-2026)
  • Figure 56. South America Vaccines & Vaccination Share (%), by Country
  • Figure 57. Asia Pacific Vaccines & Vaccination Share (%), by Country
  • Figure 58. Europe Vaccines & Vaccination Share (%), by Country
  • Figure 59. MEA Vaccines & Vaccination Share (%), by Country
  • Figure 60. North America Vaccines & Vaccination Share (%), by Country
  • Figure 61. Global Vaccines & Vaccination: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Pfizer, Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Emergent BioSolutions, Inc. (United States)
  • Johnson & Johnson (United States)
  • MedImmune, LLC (United States)
  • GlaxoSmithKline plc (UK)
  • Sanofi Pasteur (France)
  • Astellas Pharma Inc. (Japan)
  • CSL Limited (Australia)
  • Serum Institute of India Pvt. Ltd. (India)
Additional players considered in the study are as follows:
Bavarian Nordic (Denmark) , Mitsubishi Tanabe Pharma Corporation (Japan) , Daiichi Sankyo (Japan) , Biological E (India) , Panacea Biotec (India)
Select User Access Type

Key Highlights of Report


Jan 2022 219 Pages 57 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Vaccines & Vaccination Market Quantitative research analysis
Global Vaccines & Vaccination Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Vaccines & Vaccination study can be customized to meet your requirements. The market size breakdown by type [Monovalent Vaccines and Multivalent Vaccines], by end use application [Pediatrics disease and Adults disease].
The Vaccines & Vaccination Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Vaccines & Vaccination market is expected to see growth rate of 5.8%.

Know More About Global Vaccines & Vaccination Market Report?

Have a Query? Click Here

Other Related Reports

Dog Calcium Supplement Comprehensive Study by Application (Households, Veterinary Hospitals, Pet Cannels, Other), Form (Powder, Paste, Liquid, Capsules, Other), Distribution Channel (Online, Offline)...
$ 3800
Quinine Sulphate Comprehensive Study by Application (Malaria, Problematic Leg Cramps, Other), Distribution Chanel (Online, Offline), Dose (200mg, 300mg, Other) Players and Region - Global Market Outl...
$ 3500
Ear Drops Comprehensive Study by Type (Antibiotic Ear Drops, Corticosteroid Ear Drops, Antifungal Ear Drops, Acidic Ear Drops), Application (Adult, Children), Composition (Ciprofloxacin, Dexamethason...
$ 3650
Peptide Synthesis Equipment Comprehensive Study by Type (Peptide Synthesizers, Chromatography Equipment, Lyophilizers), Application (Pharmaceutical and Biotechnology Companies , Contract Development ...
$ 3750
Antibody-drug Conjugates Comprehensive Study by Type (Monoclonal Antibody, Potent Cytotoxic Agent, Linker, Others), Application (Leukemia, Glioblastoma, Lymphoma, Others), Product Type (Adcertis, Kad...
$ 3750
Hydroxycarbamide Comprehensive Study by Application (Sickle Cell Disease, Cancer, Other), Distribution Channel (Online, Offline (Hospital Pharmacy, Retail Pharmacy)), Intake Form (Capsule, Tablet, Ot...
$ 3650